← Evidence map

TrialClinical pharmacokinetics2022

Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer.

C Louwrens Braal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2022
2023
2024
2025
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34786650